Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Developing safe and effective gene delivery platforms to unlock the therapeutic power of personalized, redoseable genetic medicine.
Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.
Vector Biomed is a state-of-the-art custom vector design and GMP manufacturing company.
Antheia uses synthetic biology to produce biosynthetic KSMs and APIs for essential medicines through engineered microbial fermentation.
Valsoft specializes in the acquisition and growth of vertical-market software enterprises.
Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.
Allonnia is an environmental biotechnology company focused on metals and mining, plastics and PFAS, plus other emerging contaminants.
Cognism is a B2B sales acceleration software company that provides a marketing and sales acceleration solution.
Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.
Arcaea's mission is to build a new foundation for the beauty industry through expressive biology.
Patina is reinventing primary care for adults 65+ so everyone gets the healthcare and aging experience they deserve.
NextGen Jane is a data-driven women's health company.
1Health is a health platform that connects clinicians and patients to labs.
Humaneva is a healthacare research company that offers reliable clinical research data that empowers the medical community.
MyForest Foods grows meatless mycelium on vertical farms and supplies sustainable natural flagship products to consumers.
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Dock is a provider of a financial technology company that integrates card issuing and core banking services.
Revenova is a provider of CRM-powered transportation management systems (TMS) for 3PLs, Freight Brokers, Carriers and Shippers
Astarte Medical is clinical intelligence company providing digital solutions to support protocol-driven care across pediatric populations.
Resilient Biotics utilizes big data analytics to design microbiome-based therapeutics and advanced screening methods.
A health tech company disrupting how those struggling to conceive access specialty fertility care through the best of science and tech.
A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.
The world's First and Only Personalization Platform for Health and Wellness Products and Services Tailored to Your DNA and Lifestyle.
Viking Global Investors has invested in 54 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Viking Global Investors's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Software. The firm invests across 63 different industry categories.
Among tracked funding rounds, Zentalis Pharmaceuticals received $235.5M in a Post Ipo Equity round. Viking Global Investors's total known invested capital is $1.9B.
Viking Global Investors's average investment size is $47.7M across its portfolio of 54 companies.
Recent Viking Global Investors portfolio additions include Mediphage Bioceuticals, HI-Bio, Vector Biomed, Antheia, Valsoft. These companies were founded in 2020 or later.